CD Formulation specializes in the design of controlled release drug delivery systems for nucleic acid therapeutics. Our mission is to deliver innovative solutions tailored to our clients' needs by integrating cutting-edge technology with extensive expertise, thereby advancing the field and supporting various application requirements.
Controlled release drug delivery systems aim to optimize compound dosing and administration frequency, reduce fluctuations in compound concentration, and manage potential side effects. These systems are crafted with unique formulations that combine components with varying release speeds, ensuring that the compound reaches target concentrations swiftly at the outset and maintains the necessary levels through a sustained release mechanism. This approach ensures continuous supply and enhances stability and efficacy.
Fig.1 Medical Rationale behind controlled release drug delivery systems (CRDDS). (Adepu S, et al., 2021)
Items | Descriptions |
---|---|
Minimum Effective Concentration (MEC) | The design must ensure that nucleic acid therapeutics reach and maintain the MEC to fulfill their biological roles, achievable through frequent conventional dosing or optimized release via controlled release technologies. |
Dosage Size and Duration | Long-acting systems must account for the total drug amount a unit dose system can accommodate. Inadequate system capacity can complicate design, necessitating careful planning of drug dosing. |
Solubility | The effectiveness of nucleic acid therapeutics absorption in vivo is closely linked to their solubility. Evaluate solubility at various pH levels to ensure sufficient support for sustained absorption. Low solubility can hinder absorption and bioavailability, requiring the maintenance of the non-ionized form within ranges that enhance passive diffusion absorption in the small intestine. |
Drug Degradation and Stability | Consider the chemical and biological degradation of drugs in different environments during design to ensure stability and efficacy throughout delivery. |
Release Mechanism and Material Selection | The choice of biodegradable, drug-compatible materials, and environmental responsivity (e.g., pH and temperature sensitivity) are crucial to achieve desired release profiles and improve delivery efficiency. |
Our comprehensive services ensure efficient nucleic acid drug delivery and stability. Beginning with release optimization, we enable nucleic acid drugs to perform effectively in biosystems. By incorporating advanced controlled release technologies, we finely regulate release rates and quantities to achieve optimal biological effects. Our support spans unit dosage design to solubility optimization, tailored to diverse environmental demands.
Additionally, our service emphasizes the perfect integration of material selection and performance. We focus on selecting the best biodegradable materials to ensure predictable and consistent release. Evaluating environmental effects on drug stability is key to maintaining activity, while utilizing environment-sensitive materials allows precise release according to varying external conditions. Our strategic approach provides customized design solutions for different nucleic acid drugs.
Fig.2 Flow chart of controlled release drug delivery system design. (CD Formulation)
Engage in-depth consultations to gather client needs and project goals, clarify functional characteristics and application scenarios, analyze regulatory and standard frameworks for a foundational design direction that aligns with market demand.
Develop detailed design plans, choose suitable materials and carriers, define drug release mechanisms, consider release rates and environmental impacts, and design initial structures and preparation processes in readiness for the experimental phase.
Conduct small-scale preparation in labs, trial varied process parameters, optimize formulations, evaluate physicochemical properties, and gather data for subsequent assessments.
Conduct performance tests, including in vitro release experiments and physicochemical assessments, and evaluate release behaviors under various conditions to analyze data, understanding system stability and consistency.
Technology: Novel drug carriers developed for drug controlled release systems
Journal: Advanced drug delivery reviews
IF: 15.21
Published: 2018
Results:
New drug carriers are designed to meticulously control the timing and dosage of drug release into the body. This is achieved through "programmed" and "on-demand" approaches. The programmed method involves complex structures that regulate release rates over time, while the on-demand approach allows operators to control release via remote devices. These systems aim to create adaptable release patterns, boosting efficacy by managing the timing, duration, dosage, and location of drug release predictably and reliably.
Fig.3 Drug delivery systems for programmed and on-demand release. (Davoodi P, et al., 2018)
CD Formulation is dedicated to enhancing the delivery of nucleic acids through cutting-edge controlled release system designs. We provide customized solutions that ensure precise delivery, addressing the specific needs of each client. For more information on how our expertise can benefit your projects, please contact us.
References